Controlled and targeted drug delivery strategies towards intraperiodontal pocket diseases

Journal of Clinical Pharmacy and Therapeutics

Volumn 25, Issue 1, 2000, Pages 21-42

  Vyas, S P ^a   Sihorkar, V ^a   Mishra, V ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIMETABOLITE; AZANIDAZOLE; CHITOSAN; CHLORHEXIDINE; CLAVULANIC ACID; CLINDAMYCIN; CONCANAVALIN A; DENTOMYCIN; DOXYCYCLINE; ELYSOL; ERYTHROMYCIN; FLUORIDE; FLURBIPROFEN; IMIDAZOLE; IMIDAZOLE DERIVATIVE; KETOPROFEN; METRONIDAZOLE; MINOCYCLINE; NAPROXEN; NIRIDAZOLE; ONSITE; PENICILLIN G; PERIO CHIP; SPIRAMYCIN; TETRACYCLINE; TINIDAZOLE; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; BIODEGRADATION; BIOFILM; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; GEL; GINGIVITIS; HUMAN; IMMUNE RESPONSE; MICROBIOLOGY; MICROCAPSULE; MOUTH HYGIENE; NONHUMAN; OINTMENT; PATHOGENESIS; PERIODONTAL DISEASE; REVIEW; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; TOOTH PLAQUE;

BIOFILMS; DELAYED-ACTION PREPARATIONS; DISEASE PROGRESSION; DRUG DELIVERY SYSTEMS; HUMANS; PERIODONTAL DISEASES; PERIODONTAL POCKET;

EID: 0034021620     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2000.00261.x     Document Type: Review

References (129)

1. 1. Genco RJ, Evans RT, Ellison SA. (1969) Review of dental research in microbiology with emphasis on periodontal research. Journal of American Dental Association, 78, 1016-1023.
2. 2. Slots J. (1979) Subgingival microflora and periodontal disease. Journal of Clinical Periodontology, 6, 351-354.
3. 3. Baker PJ, Evans RT, Slots J, Genco RJ. (1985) Susceptibility of human oral anaerobic bacteria to antibiotics suitable for topical use. Journal of Clinical Periodontology, 12, 201-204.
4. 4. Williams RC. (1990) Periodontal diseases. New England Journal of Medicine, 322, 373-391.
5. 5. Chen C, Slots J. (1993) The current status and future prospects of altering the pathogenic microflora of periodontal disease. Current Opinions in Periodontology, 71-77.
6. 6. Carranza AF, Odont J, eds. (1990) Periodontal pathology. In: Glickman, AWL ed. Clinical Periodontology, 8th edn. Pennsylvania: WB Saunders Co, 330-351.
7. 7. Tortora GJ, Funke BR, Case CL, eds. (1997) Microbial diseases of the digestive system. In: Microbiology: an Introduction, 6th edn. California: Addison Wesley Longman Inc, 659-662.
8. 8. Holen S. (1975) Letter: periodontal health after destructive periodontal disease. Journal of Periodontology, 46, 570.
9. 9. Becker W, Berg L, Becker BE. (1979) Untreated periodontal disease: a longitudinal study. Journal of Periodontology, 50, 234-244.
10. 10. Lindhe J, Haffajee AJ, Socransky SS. (1983) Progression of periodontal disease in adult subjects in the absence of periodontal therapy. Journal of Clinical Periodontology, 10, 433-442.
11. 11. Buckley LA, Crowley MJ. (1984) A longitudinal study of untreated periodontal disease. Journal of Clinical Periodontology, 11, 523-530.
12. 12. Hirsh RS, Clark NG. (1989) Infection and periodontal diseases. Reviews of Infectious Diseases, 11, 707-717.
13. 13. Listgarten MA, Hellden L. (1978) Relative distribution of bacteria at clinically healthy and periodontally diseased sites in human. Journal of Clinical Periodontology, 5, 115-121.
14. 14. Newman MG, Socransky SS. (1979) Predominant cultivation of microbiota in periodontitis. Journal of Periodontal Research, 12, 120-128.
15. 15. Danser MM, Timmerman MF, van Winkelhoff AJ, van der Velden U. (1996) The effect of periodontal treatment on periodontal bacteria on the oral mucous membranes. Journal of Periodontology, 67, 478-185.
16. 16. Takehara T. (1991) Oral health status, manpower and delivery systems in a developed country - Japan. Journal of Public Health in Dentistry, 51, 260-264.
17. 17. Goodson JM. (1996) Life on a string: development of the tetracycline fiber delivery system. Technology of Health Care, 4, 269-282.
18. 18. Estaniel CP. (1995) An update on the nonsurgical treatment of periodontal diseases. Journal of Philippine Dental Association, 47, 19-26.
19. 19. Kaldahl WB, Kalkwarf KL, Patil KD. (1993) A review of longitudinal studies that compared periodontal therapies. Journal of Periodontology, 64, 243-253.
20. 20. Slots J, van-Winkelhoff AJ. (1993) Antimicrobial therapy in periodontitis. Journal of California Dental Association, 21, 51-54.
21. 21. Bader HI. (1992) Site-specific chemotherapy in periodontal management: an exiting new direction. Dental Economy, 82, 82-91.
22. 22. Addy M, Renton HP. (1996) Local and systemic chemotherapy in the management of periodontal disease: an opinion and review of concept. Journal of Oral Rehabilitation, 23, 219-231.
23. 23. Higashi K, Matsushi M, Morisaki K, Hayashi S, Mayui T. (1991) Local drug delivery systems for treatment of periodontal disease. Journal of Pharmacobio-Dynamics, 14, 72-81.
24. 24. Greenstein G, Polson A. (1998) The role of local drug delivery in the management of periodontal diseases: a comprehensive review. Journal of Periodontology, 69, 507-520.
25. 25. Goodson JM. (1994) Antimicrobial strategies for treatment of periodontal diseases. Periodontology, 2000(5), 142-168.
26. 26. Lang NP, Loe H. (1993) Clinical management of periodontal diseases. Periodontology, 2000(2), 128-139.
27. 27. Atilla G, Balcan M, Bicakci N, Kazandi A. (1996) The effect of non-surgical periodontal and adjunctive minocycline-HCL treatments on the activity of salivary proteases. Journal of Periodontology, 67, 1-6.
28. 28. Saito A, Hosaka Y, Nakagawa T, Seida K, Yamada S, Okuda K. (1994) Locally delivered minocycline and guided tissue regeneration to treat post-juvenile periodontitis. A case report. Journal of Periodontology, 65, 835-839.
29. 29. Walker CB, Gordon JM, Magnusson I, Clark WB. (1993) A role for antibiotics in the treatment of refractory periodontitis. Journal of Periodontology, 64, 772-781.
30. 30. Muller PP, Lange DE, Muller RF. (1993) A 2-year study of adjunctive minocycline HC1 in Actinobacillus actinomycetemcomitans associated periodontitis. Journal of Periodontology, 64, 509-519.
31. 31. Kornman KS, Karl EH. (1982) The effect of long-term low-dose tetracycline therapy on the subgingival flora in refectory adult periodontitis. Journal of Periodontology, 53, 604-609.
32. 32. Seymour RA, Heasman PA. (1995) Pharmacological control of periodontal disease. II. Antimicrobial agents. Journal of Dentistry, 23, 5-14.
33. 33. Gordon JM, Walker CB. (1993) Current status of systemic antibiotic usage in destructive periodontal disease. Journal of Periodontology, 64, 76-771.
34. 34. Jones MN, Kaszuba M, Lyle IG. (1992) Treatment composition. British Patent Application no. 9208339.3, Filed April 15th.
35. 35. Jenkins S, Addy M, Newcombe RG. (1994) A comparision of cetylpyridium chloride, triclosan and chlorhexidine mouthrinse formulations for effects on plaque regrowth. Journal of Clinical Periodontology, 21, 441-444.
36. 36. Tinanoff N, Hock J, Hellden L. (1980) Effect of stannous fluoride mouthrinse on dental plaque formation. Journal of Clinical Periodontology, 7, 232-239.
37. 37. Stoltze K. (1992) Systemic absorption of metronidazole after application of a metronidazole 25% dental gel. Journal of Clinical Periodontology, 19, 693-697.
38. 38. Pedrazzoli V, Kilian M, Karring T. (1992) Comparative clinical and microbiological effects of topical subgingival application of metronidazole 25% dental gel and scaling in the treatment of adult periodontitis. Journal of Clinical Periodontology, 19, 715-722.
39. 39. Wieder SG, Newman HN, Strahan JD. (1983) Stannous fluoride and subgingival chlorhexidine irrigation in the control of plaque and chronic periodontitis. Journal of Clinical Periodontology, 10, 172-176.
40. 40. Soh LL, Newman HN, Strahan JD. (1982) Effect of sublingual chlorhexidine irrigation for periodontal inflammation. Journal of Clinical Periodontology, 9, 66-74.
41. 41. Shapira L, Friedman I, Goultschin J, Sela MN, Gedalia I. (1994) Subgingival irrigation with amine fluoride-stannous fluoride gel in treated periodontal pockets. American Journal of Dentistry, 7, 235-238.
42. 42. Wan Yusof WZA, Newman HN, Strahan JD, Coventry JF. (1984) Subgingival metronidazole in dialysis tubing and subgingival chlorhexidine irrigation in the control of chronic inflammatory periodontal disease. Journal of Clinical Periodontology, 11, 166-175.
43. 43. Unsal E, Walsam TE, Walsh TF. (1994) Influence of a single application of subgingival chlorhexidine gel or tetracycline paste on the clinical parameter of adult periodontitis. Journal of Clinical Periodontology, 21, 351-355.
44. 44. Nakagawa T, Yamada S, Oosuka Y, et al. (1991) Clinical and microbiological study of minocycline delivery (Periocycline). Bulletin of the Tokyo Dental College, 32, 63-69.
45. 45. Klinge B, Altstrom R, Karring T, et al (1992) Three regimens of topical metronidazole compared with subgingival scaling on periodontal pathology in adults. Journal of Clinical Periodontology, 19, 708-714.
46. 46. Soskolne WA. (1997) Subgingival delivery of therapeutic agents in the treatment of periodontal diseases. Critical Review in Oral Biology and Medicine, 8, 164-174.
47. 47. Killoy WJ, Cobb CM. (1992) Controlled local delivery of tetracycline in the treatment of periodontitis. Compendium, 13, 1150-1154.
48. 48. Maze GI, Reinhardt RA, Agarwal RK, et al. (1995) Response to intracrevicular controlled delivery of 25% tetracycline from poly (lactide/glycolide) film strips in SPT patients. Journal of Clinical Periodontology, 22, 860-867.
49. 49. Friedman M, Steinberg D, Sela MN, Soskolne A. (1991) Structural and microbiological evaluation of a degradable sustained-release device for use in periodontal therapy. Drug Design and Delivery, 7, 241-250.
50. 50. Sridevi S, Babu RJ, Mittal N, et al. (1995) Development and evaluation of acrylic strips of metronidazole for the therapy of periodontal diseases. Pharmazie, 50, 153-154.
51. 51. Karunakar B, Sabu K, Uddupa N, Verma BRR. (1994) Dental implants of tinidazole. Drug Development and Industrial Pharmacy, 20, 409.
52. 52. Kyun KD, Yun KS, Young JS, et al (1990) Development of minocycline containing polycaprolactone film as local drug delivery. Taeban Chikkwa Visa Hyophoe Chi, 28, 279-290.
53. 53. Goodson JM, Holborow D, Dunn RL, et al. (1983) Monolithic tetracycline-containing fibers for controlled delivery to periodontal pocket. Journal of Periodontology, 54, 575-579.
54. 54. Goodson JM, Offenbacher S, Farr DH, Hogan P. (1985) Periodontal disease treatment by local drug delivery. Journal of Periodontology, 56, 265-272.
55. 55. Medlicott NJ, Rathbone MJ, Tucker IG, Holborow DW. (1994) Delivery systems for the administration of drugs to the periodontal pocket. Advanced Drug Delivery Reviews, 13, 181-203.
56. 56. Coventry J, Newman HN. (1982) Experimental use of a slow release device employing chlorhexidine gluconate in areas of acute periodontal inflammation. Journal of Clinical Periodontology, 9, 129-133.
57. 57. Addy M, Rawle L, Handley R, et al (1982) The development and in-vitro evaluation of acrylic strips and dialysis tubing for local drug delivery. Journal of Periodontology, 53, 693-699.
58. 58. Tonetti M, Cugini MA, Goodson JM. (1990) Zero-order delivery with periodontal placement of tetracycline-loaded ethylene vinyl acetate fibers. Journal of Periodontal Research, 25, 243-249.
59. 59. Lindhe J, Heijl L, Goodson JM, Socransky SS. (1979) Local tetracycline delivery using hollow fiber devices in periodontal therapy. Journal of Clinical Periodontology, 6, 141-149.
60. 60. Goodson JM, Cugini MA, Kent RL, et al. (1991) Multicenter evaluation of tetracycline fiber therapy: I. Experimental design, methods and baseline data. Journal of Periodontal Research, 26, 361-370.
61. 61. Newman MG, Kornman KS, Doherty FM. (1994) A 6-months-multicenter evaluation of adjuvantive tetracycline fiber therapy used in fiber conjunction with scaling and root planning-maintenance patients: clinical results. Journal of Periodontal Research, 65, 685-691.
62. 62. Baker RW, Farrant J. (1989) US Patent no. 4 764 377, Current U.S. Patent. Journal of Controlled Release, 9, 89.
63. 63. Soskome WA, Freidman M. (1996) Intraperiodontal pocket drug delivery systems. In: Rathbone SJ, eds. Oral Mucosal Drug Delivery. New York: Marcel Dekker Inc, 360.
64. 64. Noguchi T, Izumizawa K, Fukuda M, et al (1984) New method for local drug delivery using resorbable base material in periodontal therapy. Bulletin of Tokyo Medical and Dental University, 31, 145-153.
65. 65. Higashi K, Marisaki K, Hayashi S, et al. (1990) Local ofloxacin delivery using a controlled-release insert (PT-01) in the human periodontal pocket. Journal of Periodontal Research, 25, 1-5.
66. 66. Baker RW, Krisko EA, Kochinke F, et al. (1988) A controlled release drug delivery system for periodontal pocket. International Symposium on Controlled Release Bioactive Materials USA. Controlled Release Society, 238a-238b.
67. 67. Larsen T. (1990) In vitro release of doxycycline from bio-absorbable materials and acrylic strips. Journal of Periodontology, 61, 30-34.
68. 68. Collins AE, Desay PB, MacCarthy DJ, Shanely DB. (1989) Evaluation of controlled release compact containing tetracycline hydrochloride bonded to tooth for the treatment of periodontal diseases. International Journal of Pharmaceutics, 51, 103-114.
69. 69. Minabe M, Takeuchi K, Tomomatsu E, et al. (1989) Clinical effects of local application of collagen film-immobilized tetracycline. Journal of Clinical Periodontology, 16, 291-294.
70. 70. Addy M, Langeroudi M. (1984) Comparison of the immediate effects on the subgingival microflora of acrylic strips containing 40% chlorhexidine, metronidazole or tetracycline. Journal of Clinical Periodontology, 11, 379-386.
71. 71. Addy M, Hassan H, Moran J, et al. (1988) Use of antimicrobial containing acrylic strips in the treatment of chronic periodontal disease. A three-month follow-up study. Journal of Periodontology, 59, 557-564.
72. 72. Polson AM, Stoller NH, Hanes PJ, Bandt CL, Garrett S, Southard GL. (1996) Two multi-center trials assessing the clinical efficacy of 5% sanguinarine in a biodegradable drug delivery system. Journal of Clinical Periodontology, 23, 782-788.
73. 73. Friedman M, Golomb G. (1982) New sustained release dosage form of chlorhexidine for dental use. Journal of Periodontal Research, 17, 323-328.
74. 74. Soskolne A, Golomb G, Friedman M, Sela MN. (1983) New sustained release dosage form of chlorhexidine for dental use. Journal of Periodontal Research, 18, 330-336.
75. 75. Golomb G, Friedman M, Soskolne WA, et al. (1984) Sustained release device containing metronidazole for periodontal use. Journal of Dental Research, 63, 1149-1153.
76. 76. Elkayam R, Friedman M, Stabholz A, et al. (1988) Sustained release device containing minocycline for local treatment of periodontal disease. Journal of Controlled Release, 7, 231-236.
77. 77. Azoury R, Elkayam R, Friedman M. (1988) Nuclear magnetic resonance study of an ethyl cellulose sustained-release delivery system. II: Release rate behavior of tetracycline. Journal of Pharmaceutical Sciences, 77, 428-433.
78. 78. Stabholz A, Sela MN, Friedman M, et al. (1986) Clinical and microbiological effects of sustained release chlorhexidirte in periodontal pockets. Journal of Clinical Periodontology, 13, 783-788.
79. 79. Stabholz A, Soskolne WA, Friedman M, Sela MN. (1991) The use of sustained release delivery of chlorhexadine for the maintenance of periodontal pockets: 2-year clinical trial. Journal of Periodontology, 62, 429-433.
80. 80. Medlicott NJ, Jones DS, Tucker IG, Holborow D. (1992) Preliminary release studies of chlorhexdine (base and diacetate) from poly (& -caprolactone) films prepared by solvent evaporation. International Journal of Pharmaceutics, 84, 85-89.
81. 81. Desay PB, Collins AEM, MacCarthy DJ, Russel RJ. (1989) Use of strips containing tetracycline hydrochloride or metronidazole for the treatment of advanced periodontal diseases. Journal of Pharmacy and Pharmacology, 41, 694-699.
82. 82. Dunn RL, Perkins BH, Goodson JM. (1983) Controlled release of tetracycline from biodegradable fibers. Journal of Dental Research, 62, 289-294.
83. 83. Steinberg D, Friedman M, Soskolne A, Sela MN. (1990) A new degradable controlled release device for treatment of periodontal disease: in-vitro release study. Journal of Periodontology, 61, 393-398.
84. 84. Hitzig C, Charbit Y, Bitton C, et al. (1994) Topical metronidazole as an adjunct to subgingival debritment in the treatment of anaerobic periodontitis. Journal of Clinical Periodontology, 21, 146-151.
85. 85. Dedein VR, Solov'eva NI, Ezikian TI, Medvedeva IA. (1997) The treatment of periodontal diseases using Diplen-Denta films with chlorhexidine (a clinico-laboratory study). Stomatologiia-Mosk, 76, 18-22.
86. 86. van Steenberghe D, et al. (1994) Antibiotic gels for periodontal disease. Drug and Therapeutic Bulletin, 32, 43-44.
87. 87. Norling T, Loding P, Engstrom S, et al. (1992) Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease. Journal of Clinical Periodontology, 19, 687-692.
88. 88. Lawter JR, Lanzilotti M, Brizzolara N, et al. (1990) Sustained drug delivery to the periodontal pocket. International Symposium on Controlled Release Bioactive Materials USA. Controlled Release Society, 230-231.
89. 89. Kornman KS. (1993) Controlled release local drug delivery antimicrobials in periodontics: perspective for the future. Journal of Periodontology, 64, 782-791.
90. 90. Levin-Goldstein D. (1992) The local drug delivery of tetracycline, metronidazole and chlorhexidine in periodontal therapy. Journal of Dental Hygiene, 66, 410-416.
91. 91. Fiorellini JP, Paquette DW. (1992) The potential role of controlled release system delivery systems for chemotherapeutic agents in periodontics. Current Opinions in Dentistry, 2, 63-79.
92. 92. Killoy WJ, Polson AM. (1998) Controlled local delivery of antimicrobials in the treatment of periodontitis. Dental Clinics of North America, 42, 263-283.
93. 93. Southard GL, Godowski KC. (1998) Subgingival-controllrd release of antimicrobial agents in the treatment of periodontal diseases. International Journal of Antimicrobial Agents, 9, 239-253.
94. 94. Shani S, Friedman M, Steinberg D. (1998) In vitro assessment of the antimicrobial activity of a local sustained release device containing amine flouride for the treatment of oral infectious diseases. Diagnosis of Microbial Infectious Diseases, 30, 93-97.
95. 95. Greene PR. (1997) Locally delivered antimicrobials in periodontal therapy. Dental Update, 24, 204-207.
96. 96. Rethman J, Rehtman M, Suzuki J. (1995) Controlled release periodontal chemotherapy: the evolution of antimicrobial delivery systems. Pract. Periodontics Aesthet. Dent., 7, 1-8.
97. 97. Greenstein G. (1995) Treating periodontal diseases with tetracycline-impregnated fibers: data and controversies. Compendium on Continuing Education in Dentistry, 16, 448-455.
98. 98. Costerton JW, Lewandowski Z, Debeer D, Caldwell D, Korber D, James G. (1994) Biofilms, the customized microniche. Journal of Bacteriology, 176, 2137-2142.
99. 99. Donoghue HD, Perrons CJ. (1988) Establishment of defined mixed bacterial plaques on teeth in a laboratory microcosm (model mouth). Microbiology and Ecology in Health and Disease, 1, 193-200.
100. 100. Marsh PD, Bradshaw DJ. (1995) Dental plaque as a biofilm. Journal of Industrial Microbiology, 15, 169-175.
101. 101. Milward TA, Wilson M. (1989) The effect of chlorhexidine on Streptococcus sanguis biofilms. Microbios, 58, 155-164.
102. 102. Anwar H, Dasgupta MK, Costerton JW. (1990) Testing the susceptibilities of bacteria in biofilms to antibacterial agents. Antimicrobial Agents and Chemotherapy, 34, 2043-2046.
103. 103. Wilson M. (1996) Susceptibilities of oral bacterial biofilms to antimicrobial agents. Journal of Medical Microbiology, 44, 79-87.
104. 104. Thrower Y, Pinney RJ, Wilson M. (1997) Susceptibilities of Actinobacillus actinomycetemcomitans biofilms to oral antiseptics. Journal of Medical Microbiology, 46, 425-429.
105. 105. Pratten J, Wilson M. (1997) Effect of antiseptics on formation and viability of Sterptococcal biofilms. Advances in Dental Research, 11, 190.
106. 106. Pratten J, Smith AW, Wilson M. (1998) Response of single species biofilms and microcosm dental plaques to pulsing with chlorhexidine. Journal of Antimicrobial Chemotherapy, 42, 453-459.
107. 107. Pratten J, et al. (1998) In vitro studies of the effect of antiseptic-containing mouthwashes on the formation and viability of Streptococcus sanguis biofilms. Journal of Applied Microbiology, 84, 1149-1155.
108. 108. Jones MN, Kaszuba M. (1994) Polyhydroxy-mediated interaction between liposomes and bacterial bio-films. Biochimica et Biophysica Acta, 1193, 48-54.
109. 109. Sanderson NM, Jones MN. (1996) Encapsulation of vancomycin and gentamycin within cationic liposomes for inhibition of growth of Staphylococcus epidermidis. Journal of Drug Targeting, 4, 181-189.
110. 110. Jones MN, Kaszuba M, Reboiras MD, et al. (1994) The targeting of phospholipid liposomes to bacteria. Biochimica et Biophysica Acta, 1196, 57-64.
111. 111. Jones MN, Kaszuba M, Hill KJ, Song YH, Creeth JE. (1994) The use of phospholipid liposomes for targeting to oral and skin-associated bacteria. Journal of Drug Targeting, 2, 381-389.
112. 112. Jones MN, Francis SE, Hutchinson FJ, Lyle IG. (1992) Targeting and delivery of bactericide to adsorbed oral bacteria by use of proteoliposomes. Patent Application no. 9022298.5. Published April 15th.
113. 113. Marsh PD. (1990) Dentifrices containing new agents for the control of plaque and gingivitis: microbiological aspects. Journal of Clinical Periodontology, 18, 462-467.
114. 114. Jones MN, Song YH, Kaszuba M, Reboiras MD. (1997) The interaction of phospholipid liposomes with bacteria and their use in the delivery of bactericide. Journal of Drug Targeting, 5, 25-34.
115. 115. Robinson AM, Creeth JE, Jones MN. (1998) The specificity and affinity of immunoliposome targeting to oral bacteria. Biochimica et Biophysica Acta, 1369, 278-286.
116. 116. Needleman IG, Smales FC. (1995) In vitro assessment of bioadhesion for periodontal and buccal delivery. Biomaterials, 16, 617-624.
117. 117. Jones DS, Woolfson AD, Djokic J, Coulter WA. (1996) Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharmaceutical Research, 13, 1734-1738.
118. 118. Needleman IG, Martin GP, Smales FC. (1998) Characterization of bioadhesives for periodontal and oral mucosal drug delivery. Journal of Clinical Periodontology, 25, 74-82.
119. 119. De Lissovoy G, Rentz AM, Dukes EM, et al. (1999) The cost-effectiveness of a new chlorhexidine delivery system in the treatment of adult periodontitis. Journal of American Dental Association, 30, 855-862.
120. 120. Roskos KV, Fritzinger BK, Rao SS, Armitage GC, Heller J. (1995) Development of a drug delivery system for the treatment of periodontal disease based on bioerodible poly (ortho esters). Biomaterials, 16, 313-317.
121. 121. Magnusson I. (1998) The use of locally delivered metronidazole in the treatment of periodontitis. Clinical results. Journal of Clinical Periodontology, 25, 959-963.
122. 122. Stoller NH, Johnson LR, Trapnell S, Harrold CQ, Garrett S. (1998) The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum. Journal of Periodontology, 69, 1085-1091.
123. 123. Garrett S, Johnson L, Drisko CH, et al. (1999) Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis. Journal of Periodontology, 70, 490-503.
124. 124. Killoy WJ. (1999) Assessing the effectiveness of locally delivered chlorhexidine in the treatment of periodontitis. Journal of American Dental Association, 130, 567-570.
125. 125. Kinane DF, Radvar M. (1999) A six-month comparison of three periodontal local antimicrobial therapies in persistent periodontal pockets. Journal of Periodontology, 70, 1-7.
126. 126. Agarwal RK, Robinson DH, Maze GI, Reinhardt RA. (1993) Development and characterization of tetracycline-poly (lacride/glycolide) films for the treatment of periodontitis. Journal of Controlled Release, 23, 157-163.
127. 127. Yamagami H, Takamori A, Sakamoto T, Okada H. (1992) Intrapocket chemotherapy in adult periodontitis using controlled release insert containing ofloxacin (PT01). Journal of Periodontology, 63, 2-6.
128. 128. Salvi GE, Williams RC, Offenbacher S. (1997) Nonsteriodal anti-inflammatory drugs as adjuncts in the management of periodontal diseases and peri-implantitis. Current Opinions in Periodontology, 4, 51-58.
129. 129. McCaulty LK, Somerman MJ. (1998) Biological modifier in periodontal regeneration. Dental Clinics of North America, 42, 361-387.